Health Products

Yaz Plus Tablet (2018-07-12)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
71010AYaz Plus Tablet
Recalling Firm
Bayer Inc.
2920 MATHESON BLVD. EAST
MISSISSAUGA
L4W 5R6
Ontario
CANADA
Marketing Authorization Holder
Bayer Inc.
2920 MATHESON BLVD. EAST
MISSISSAUGA
L4W 5R6
Ontario
CANADA
TabletDIN 02387433DROSPIRENONE 3.00 MG

Introduction

Recalled Products

Yaz Plus Tablet

Reason

The dosage uniformity test is out of specification in the affected lots.

Depth of distribution

Wholesalers, Healthcare Establishments
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime